Actinic Keratosis of Face and Scalp

2

Review clinical trials related to Actinic Keratosis of Face and Scalp. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis

The goal of this clinical trial is to show superiority of Veregen® 10% ointment to Placebo measured by complete (100%) clearance of a pre-defined treatment area (TA) following a treatment period of 12 weeks and a 4-weeks post-treatment (PT) period (i.e., after 16 weeks at most in patients without complete clearance at the end of the treatment (EoT) period).

Participants needed: 280
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Aresus Pharma GmbHUpdated: Aug 22, 2025Locations: 1
Eligibility criteria

Patients willing to participate, obtained written informed consent. [+5]

TA is within 5 cm of an incompletely healed wound or infected area of the skin. [+24]

Status: Not yet recruiting

Efficacy of Topical 5-Fluorouracil Vs Calcipotriol As Photodynamic Therapy Pre-treatment for Field Actinic Keratoses

The purpose of this study is to compare two different creams (5-fluorouracil, known as Efudix, and calcipotriol, known as Dovonex) to see which one works better when used before Photodynamic Therapy (PDT) to treat sun-damaged skin on the scalp (called actinic keratoses). PDT is often used on its own to treat these spots, but it doesn't always remove them completely. Using Efudix or Dovonex before PDT might improve the results, but we don't yet know which is better. The main questions are - 1. Is efudix or dovonex better at treating actinic keratoses when used prior to PDT 2. Is efudix or dovonex more tolerable for patients? Participants will be randomised to treat their scalp with efudix or dovonex for seven days prior to their first PDT treatment. They will be reviewed on day 7, prior to starting PDT, and again a week later when they present for their second PDT treatment. During follow up, patients will be reviewed at 28 days, 3, 6, 9, and 12 months after treatment. At each of these visits, the number of actinic keratoses will be counted, graded, mapped and photographed to allow assessment of improvement before and after treatment.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: St Vincent's University Hospital, IrelandUpdated: Nov 12, 2024
Eligibility criteria

Adult (>18 years old) [+2]

Immunosuppression [+4]